Building the future of cancer care.
Luminate builds technologies help providers deliver better, faster, and lower cost care for patients.
SUBCUTANEOUS PORT ACCESS DEVICE
ENABLING HOME INFUSIONS WITH LOTUS
Lotus is designed to enable patients to complete low-risk procedures like drawing blood samples and infusing low-risk anti-cancer medications at home.
PRODUCTS ON TRIAL AT
WHY WE DO IT
CANCER INCIDENCE CONTINUES TO RISE
As our population ages and methods of screening improve, the increasing absolute number of patients requiring cancer treatment will need solutions.
WHILE SPENDING ON CANCER SPIRALS
US federal spending alone on cancer care is projected to grow to over $245 billion by 2030. Meanwhile, more than half of employers view cancer care as the primary driver of their healthcare costs.
AS CLINICS SUFFER A CAPACITY CRISIS
Over half of US oncology infusion clinics are already overbooked, while 40% don't have the capacity to expand without significant capital investment.
Ref: Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical Care Costs Associated with Cancer Survivorship in the United States. Cancer Epidemiol Biomarkers Prev June 10 2020 DOI: 10.1158/1055-9965.EPI-19-1534
CONTACT US
Want to learn more?
WHO WE ARE
We build powerful healthcare technology with a commitment to being people first.
5 things to bring to your first chemo session
It's only natural that you would have questions and maybe even worries prior to your first chemotherapy treatment. Your care team will discuss your chemotherapy plan...
Luminate Medical Raises Oversubscribed Seed Round
Luminate Medical, an Irish startup developing devices to eliminate hair loss during chemotherapy announced that it has raised more than...
Shape the face of cancer treatment with a career at Luminate.
We design and build products that empower cancer patients. If you're a creative problem-solver, apply for one of our open roles.